His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.
The study notes that overweight and obesity have been a growing problem for the United States for years. Obesity rates for adults and older adolescents doubled over the past three decades, and the ...
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...
The Healthy on MSN8h
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback